While greater focus has been given to HIF-1a[30], recent findings have indicated that HIF-2a is preferentially expressed in glioma cancer stem cells and correlates negatively with patient survival in clinical glioblastoma[7,31]. The gene discussed is EPAS1; the disease is central nervous system cancer.